US biotechnology firm Moderna on Monday said lab studies showed its Covid-19 vaccine would remain protective against variants of the coronavirus first identified in the United Kingdom and South Africa. "The study showed no significant impact" on the level of neutralizing antibodies elicited against the UK variant, B.1.1.7.Monday, 25 January 2021
US biotechnology firm Moderna on Monday said lab studies showed its Covid-19 vaccine would remain protective against variants of the coronavirus first identified in the United Kingdom and South Africa. "The study showed no significant impact" on the level of neutralizing antibodies elicited against the UK variant, B.1.1.7.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment